Log in

NYSE:NHINational Health Investors Stock Price, Forecast & News

$62.35
+0.27 (+0.43 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$61.63
Now: $62.35
$63.15
50-Day Range
$55.93
MA: $59.85
$64.54
52-Week Range
$31.37
Now: $62.35
$91.12
Volume310,303 shs
Average Volume372,929 shs
Market Capitalization$2.78 billion
P/E Ratio14.81
Dividend Yield7.10%
Beta0.83
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Read More
National Health Investors logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.54 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
CUSIP63633D10
Phone615-890-9100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$318.08 million
Cash Flow$5.61 per share
Book Value$34.08 per share

Profitability

Net Income$160.46 million

Miscellaneous

Employees16
Market Cap$2.78 billion
Next Earnings Date8/10/2020 (Confirmed)
OptionableOptionable
$62.35
+0.27 (+0.43 %)
(As of 08/5/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NHI News and Ratings via Email

Sign-up to receive the latest news and ratings for NHI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











National Health Investors (NYSE:NHI) Frequently Asked Questions

How has National Health Investors' stock been impacted by COVID-19 (Coronavirus)?

National Health Investors' stock was trading at $70.86 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NHI stock has decreased by 12.0% and is now trading at $62.35.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of National Health Investors?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for National Health Investors
.

When is National Health Investors' next earnings date?

National Health Investors is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for National Health Investors
.

How can I listen to National Health Investors' earnings call?

National Health Investors will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were National Health Investors' earnings last quarter?

National Health Investors Inc (NYSE:NHI) announced its quarterly earnings results on Monday, May, 11th. The real estate investment trust reported $1.37 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.40 by $0.03. The real estate investment trust earned $83.08 million during the quarter, compared to the consensus estimate of $80.77 million. National Health Investors had a return on equity of 12.62% and a net margin of 57.16%. The firm's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the company posted $1.31 earnings per share.
View National Health Investors' earnings history
.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors announced a quarterly dividend on Monday, June 15th. Stockholders of record on Tuesday, June 30th will be given a dividend of $1.102 per share on Friday, August 7th. This represents a $4.41 dividend on an annualized basis and a yield of 7.07%. The ex-dividend date of this dividend is Monday, June 29th.
View National Health Investors' dividend history
.

What price target have analysts set for NHI?

7 analysts have issued 12-month price targets for National Health Investors' shares. Their forecasts range from $40.00 to $94.00. On average, they anticipate National Health Investors' stock price to reach $66.83 in the next year. This suggests a possible upside of 7.2% from the stock's current price.
View analysts' price targets for National Health Investors
.

Has National Health Investors been receiving favorable news coverage?

Media coverage about NHI stock has been trending somewhat negative on Thursday, according to InfoTrie. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. National Health Investors earned a news sentiment score of -1.4 on InfoTrie's scale. They also gave news stories about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
View the latest news about National Health Investors
.

Are investors shorting National Health Investors?

National Health Investors saw a decrease in short interest in June. As of June 30th, there was short interest totaling 989,000 shares, a decrease of 6.7% from the June 15th total of 1,060,000 shares. Based on an average daily volume of 437,700 shares, the days-to-cover ratio is currently 2.3 days. Approximately 2.4% of the company's shares are short sold.
View National Health Investors' Current Options Chain
.

Who are some of National Health Investors' key competitors?

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), ANNALY CAP MGMT/SH (NLY), Energy Transfer LP Unit (ET), Cisco Systems (CSCO), AbbVie (ABBV), Realty Income (O), Omega Healthcare Investors (OHI), Broadcom (AVGO), EPR Properties (EPR) and Simon Property Group (SPG).

Who are National Health Investors' key executives?

National Health Investors' management team includes the following people:
  • Mr. D. Eric Mendelsohn, Pres & CEO (Age 57)
  • Mr. John L. Spaid, Exec. VP of Fin. (Age 59)
  • Mr. Kevin Carlton Pascoe, Chief Investment Officer (Age 38)
  • Mr. Roger R. Hopkins, Chief Accounting Officer (Age 57)
  • Ms. Colleen Schaller, Director, Investor Relations

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Hamlin Capital Management LLC (1.93%), Principal Financial Group Inc. (1.11%), LSV Asset Management (0.78%), ProShare Advisors LLC (0.28%), Swiss National Bank (0.22%) and Sumitomo Mitsui Trust Holdings Inc. (0.22%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, James R Jobe, Kevin Carlton Pascoe, Kristin Sallee Gaines, Robert A Mccabe Jr, Robert A Mccabe, Jr, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends for National Health Investors
.

Which major investors are selling National Health Investors stock?

NHI stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Principal Financial Group Inc., Bessemer Group Inc., UBS Group AG, Jaguar Listed Property LLC, WINTON GROUP Ltd, Meritage Portfolio Management, and ProShare Advisors LLC. Company insiders that have sold National Health Investors company stock in the last year include D Eric Mendelsohn, James R Jobe, and Kevin Carlton Pascoe.
View insider buying and selling activity for National Health Investors
.

Which major investors are buying National Health Investors stock?

NHI stock was acquired by a variety of institutional investors in the last quarter, including Hamlin Capital Management LLC, LSV Asset Management, Russell Investments Group Ltd., GW Henssler & Associates Ltd., Swiss National Bank, Dupont Capital Management Corp, Zurcher Kantonalbank Zurich Cantonalbank, and Raymond James & Associates. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams.
View insider buying and selling activity for National Health Investors
.

How do I buy shares of National Health Investors?

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $62.35.

How big of a company is National Health Investors?

National Health Investors has a market capitalization of $2.78 billion and generates $318.08 million in revenue each year. The real estate investment trust earns $160.46 million in net income (profit) each year or $5.50 on an earnings per share basis. National Health Investors employs 16 workers across the globe.

What is National Health Investors' official website?

The official website for National Health Investors is www.nhireit.com.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at 615-890-9100 or via email at [email protected]

This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.